Cargando…

Corrigendum: Functional variant rs12614 in CFB confers a low risk of IgA nephropathy by attenuating complement alternative pathway activation in Han Chinese

Detalles Bibliográficos
Autores principales:	Shi, Dian-Chun, Feng, Shao-Zhen, Zhong, Zhong, Cai, Lu, Wang, Meng, Fu, Dong-Ying, Yu, Xue-Qing, Li, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731908/ https://www.ncbi.nlm.nih.gov/pubmed/36505473 http://dx.doi.org/10.3389/fimmu.2022.1098003

Ejemplares similares

Functional variant rs12614 in CFB confers a low risk of IgA nephropathy by attenuating complement alternative pathway activation in Han Chinese
por: Shi, Dian-Chun, et al.
Publicado: (2022)

Role of complement in IgA nephropathy
por: Daha, Mohamed R., et al.
Publicado: (2015)

Complement activation in IgA nephropathy
por: Medjeral-Thomas, Nicholas R., et al.
Publicado: (2021)

Targeting complement in IgA nephropathy
por: Caravaca-Fontán, Fernando, et al.
Publicado: (2023)

Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA(1) Antibody in IgA Nephropathy Patients
por: Chiu, Yen-Ling, et al.
Publicado: (2021)

A non-synonymous variant rs12614 of complement factor B associated with risk of chronic hepatitis B in a Korean population
por: Seo, Jung Yeon, et al.
Publicado: (2020)

Complement Activation Is Associated With Crescents in IgA Nephropathy
por: Wang, Zi, et al.
Publicado: (2021)

The Role of Complement in Microangiopathic Lesions of IgA Nephropathy
por: Li, Jingyi, et al.
Publicado: (2022)

Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study
por: Rizk, Dana V., et al.
Publicado: (2023)

Challenges in IgA Nephropathy Management: An Era of Complement Inhibition
por: Tesař, Vladimir, et al.
Publicado: (2023)

Identification of new susceptibility loci for IgA nephropathy in Han Chinese
por: Li, Ming, et al.
Publicado: (2015)

Corrigendum: Concurrent IgA nephropathy and membranous nephropathy, is it an overlap syndrome?
por: He, Jia-Wei, et al.
Publicado: (2023)

Diagnosis and treatment of IgA nephropathy and IgA vasculitis nephritis in Chinese children
por: Zhong, Xuhui, et al.
Publicado: (2022)

The interaction effect of rs4077515 and rs17019602 increases the susceptibility to IgA nephropathy
por: Wu, Changwei, et al.
Publicado: (2017)

The prognostic value of plasma complement factor B (CFB) in thyroid carcinoma
por: Wu, Pu, et al.
Publicado: (2021)

Determination of IL-1B (rs16944) and IL-6 (rs1800796) genetic polymorphisms in IgA nephropathy in a northwest Chinese Han population
por: Zhang, Daofa, et al.
Publicado: (2017)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Risk alleles for IgA nephropathy-associated SNPs conferred completely opposite effects to idiopathic membranous nephropathy in Chinese Han
por: Qin, Xiaosong, et al.
Publicado: (2017)

The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy
por: Rizk, Dana V., et al.
Publicado: (2019)

A bibliometric analysis of complement in IgA nephropathy from 1991 to 2022
por: Guo, Yun, et al.
Publicado: (2023)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Corrigendum to “Upregulated Expression of Intestinal Antimicrobial Peptide HD5 Associated with Renal Function in IgA Nephropathy”
por: Feng, Shaozhen, et al.
Publicado: (2022)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Overactivation of the complement system may be involved in intrarenal arteriolar lesions in IgA nephropathy
por: Guo, Wei-yi, et al.
Publicado: (2022)

Urinary complement profile in IgA nephropathy and its correlation with the clinical and pathological characteristics
por: Wang, Dongqing, et al.
Publicado: (2023)

TLR1 polymorphism rs4833095 as a risk factor for IgA nephropathy in a Chinese Han population: A case-control study
por: Gao, Jie, et al.
Publicado: (2016)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Associations between Biomarkers of Complement Activation, Galactose-Deficient IgA1 Antibody and the Updated Oxford Pathology Classification of IgA Nephropathy
por: Juan, Yun-Ting, et al.
Publicado: (2022)

Astragalus membranaceus up-regulate Cosmc expression and reverse IgA dys-glycosylation in IgA nephropathy
por: Ji, Ling, et al.
Publicado: (2014)

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
por: Sukcharoen, Kittiya, et al.
Publicado: (2020)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
por: Tota, Maciej, et al.
Publicado: (2023)

A Functional Variant rs3093023 in CCR6 Is Associated With IgA Nephropathy by Regulating Th17 Cells in a North Han Chinese Population
por: Zhang, Yue-miao, et al.
Publicado: (2021)

The genetic variants at the HLA-DRB1 gene are associated with primary IgA nephropathy in Han Chinese
por: Jiyun, Yang, et al.
Publicado: (2012)

Rapidly progressive IgA nephropathy: a form of vasculitis or a complement-mediated disease?
por: Rojas-Rivera, Jorge, et al.
Publicado: (2015)

Thrombotic Microangiopathy in IgA Nephropathy
por: Nasri, Hamid
Publicado: (2013)

Nutcracker phenomenon in IgA nephropathy
por: Imai, Naohiko, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_45i96ih54if8p2t86chggi4j7r